U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536048) titled 'A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years' on March 31.
Brief Summary: This multi-center, prospective, longitudinal cohort study is designed to gather immunological and clinical data on EBV reactivation in EBV seropositive adults aged 18 to 29 years.
This study will follow a cohort of approximately 100 EBV seropositive adults 18 to 29 years of age in Australia over a 6 or 12-month period.
Participants will not receive any study intervention (eg, study treatments, vaccines).
Study Start Date: April 20
Study Type: OBSERVATIONAL
Condition:
Epstein-Barr Virus (EBV)
Healthy Volunte...